Phase 1 study of PCSK9 mRNA inhibitors

Trial Profile

Phase 1 study of PCSK9 mRNA inhibitors

Planning
Phase of Trial: Phase I

Latest Information Update: 10 Jan 2017

At a glance

  • Drugs Antisense oligonucleotides (Primary) ; PCSK9 protein inhibitors (Primary)
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Jan 2017 New trial record
    • 05 Jan 2017 According to a CiVi Biopharma media release, this trial is expected to start in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top